您的位置：
首页
>
农业专利
>
详情页
AMINONAPTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES
专利权人:
Bridgent Biotechnology Inc.
发明人:
Yun YEN,Jing-ping LIOU,Shiow-lin PAN
申请号：
US16740167
公开号：
US20200148643A1
申请日:
2020.01.10
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to new compounds with low cytotoxicity for blocking the ubiquitination-proteasome system in diseases. Accordingly, these compounds can be used in treatment of disorders including, but not limited to, cancers, neurodegenerative diseases, inflammatory disorders, autoimmune disorders and metabolic disorders.
来源网站：
中国工程科技知识中心
来源网址：
http://www.ckcest.cn/home/
相关专利
Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
Aminonapthoquinone compounds and pharmaceutical composition for blocking ubiquitination-proteasome system in diseases
AMINONAPTHOQUINONE COMPOUNDS AND PHARMACEUTICAL COMPOSITION FOR BLOCKING UBIQUITINATION-PROTEASOME SYSTEM IN DISEASES
IDO INHIBITORS
compound, pharmaceutical composition, method for treating an autoimmune disease, pharmaceutical composition for preventing or treating cancers, tumors, inflammatory diseases, autoimmune diseases or immunologically mediated disease, and method for treating an autoimmune disease, cancers, tumors, inflammatory diseases or immunologically mediated diseases
